COVID-19 Update - This is to inform you that the Government of India has announced a complete lockdown in India 22nd March 2020 to 14th April 2020. As a result, our offices will now be closed till 14th April 2020 and all our employees will be working from home. Office telephones will not be answered, and therefore you are requested to direct all your queries related to manuscript submission, review process, publication etc. at below mentioned details. editor@innovativepublication.com, rakesh.its@gmail.com, Mob. 8826373757, 8826859373, 9910947804

Article view: 390

Article download: 166

IP International Journal of Medical Paediatrics and Oncology


Herpes simplex induced erythema multiforme – A case report


Full Text PDF Share on Facebook Share on Twitter


Author Details : Raghavendra H. Gobbur*, Sanjeevini Umrani

Volume : 4, Issue : 3, Year : 2018

Article Page : 131-132


Suggest article by email

Abstract

Erythema Multiforme is an acute inflammatory muco-cutaneous hypersensitive reaction with varied aetiology and various degrees of blistering and ulceration. Viral aetiology is most common. We report a case of herpes induced Erythema Multiforme who was managed with acyclovir. The 11 year old boy presented with pain and ulceration over his lips, target shaped lesions on palms and fever. The episode was not drug related. The presentation suggested Herpes associated Erythema Multiforme which was confirmed by Serology positive for Herpes simplex virus. The patient was treated with acyclovir for 7 days and his illness subsided. The early suspicion and initiation of treatment is necessary in management of this life threatening mucocutaneous disorder.

Keywords: Herpes simplex, Erythema Multiforme, target lesions, acyclovir

Doi : 10.18231/2581-4702.2018.0029

How to cite : Gobbur R H , Umrani S , Herpes simplex induced erythema multiforme – A case report. IP Int J Med Paediatr Oncol 2018;4(3):131-132

Copyright © 2018 by author(s) and IP Int J Med Paediatr Oncol. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (CC BY 4.0) (creativecommons.org)